What does a fecal calprotectin level of 88 µg/g indicate in a 6‑month‑old infant and how should it be evaluated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fecal Calprotectin of 88 µg/g in a 6-Month-Old Infant

A fecal calprotectin level of 88 µg/g in a 6-month-old infant is within the normal range for this age group and does not indicate pathological intestinal inflammation requiring intervention.

Age-Specific Normal Values

The critical context here is that infants under 6 months have markedly elevated baseline fecal calprotectin levels compared to older children and adults. The established age-specific reference ranges are 1:

  • Under 6 months: Up to 538 µg/g (97.5th percentile)
  • 6 months to 3 years: Up to 214 µg/g (97.5th percentile)
  • 3 to 4 years: Up to 75 µg/g (97.5th percentile)
  • Over 4 years: <50 µg/g (adult cutoff)

At 88 µg/g, this infant's level falls well below the upper limit of normal for the 6-month to 3-year age bracket (214 µg/g).

Why Infants Have Higher Baseline Levels

Exclusively breastfed infants demonstrate significantly higher fecal calprotectin levels than formula-fed infants (median 555 µg/g vs. 206.6 µg/g, p<0.001) 2. This elevation is physiologic, likely related to:

  • Immunostimulating factors in breast milk (cytokines, growth factors)
  • Normal development of the gastrointestinal immune system
  • Hormones and bioactive compounds (ghrelin, leptin, epidermal growth factor)

Rural infants also show higher levels than urban infants (median 420.9 vs. 140.1 µg/g) 3, though the clinical significance of this finding remains unclear.

Clinical Interpretation for This Patient

No further workup is indicated based on this fecal calprotectin level alone. The value of 88 µg/g suggests:

  • No inflammatory bowel disease: The adult IBD guidelines use cutoffs of 50-150 µg/g 4, but these are explicitly not applicable to infants under 4 years
  • No milk protein allergy: Infants with confirmed milk protein allergy show median levels of 410 µg/g 5 and 324.45 µg/g 6, substantially higher than this patient's value

When to Be Concerned in Infants

Consider pathological causes if the infant has:

  • Persistent bloody stools with fecal calprotectin >200-300 µg/g
  • Failure to thrive (declining growth percentiles) with elevated calprotectin
  • Clinical symptoms of milk protein allergy (bloody stools, vomiting, poor weight gain) where levels typically exceed 300-400 µg/g 5, 6

Common Pitfalls to Avoid

  1. Do not apply adult cutoffs (<50 µg/g) to infants - this leads to massive overdiagnosis and unnecessary invasive testing
  2. Do not interpret isolated elevated calprotectin without clinical context - feeding type, symptoms, and growth parameters are essential
  3. Do not repeat testing without clinical indication - physiologic elevation in healthy infants does not require serial monitoring

Bottom Line

This 6-month-old's fecal calprotectin of 88 µg/g requires no action if the infant is asymptomatic, growing appropriately, and has no concerning gastrointestinal symptoms. Clinical assessment of growth, feeding tolerance, and stool characteristics should guide any further evaluation—not the calprotectin value itself.

References

Research

Fecal calprotectin in healthy children.

Scandinavian journal of clinical and laboratory investigation, 2014

Research

Can fecal calprotectin levels be used to monitor infant milk protein allergies?

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2021

Research

[Diagnostic value of fecal calprotectin detection in infants with milk protein-allergic enteritis].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.